Literature DB >> 24212369

Platelet-rich plasma for articular cartilage repair.

Geoffrey D Abrams1, Rachel M Frank, Lisa A Fortier, Brian J Cole.   

Abstract

Platelet concentrates have been gaining popularity for a number of applications in orthopedic surgery as a way to enhance both healing of various tissues and reduce pain. One major area of focus has been the effect of platelet-rich plasma (PRP) on stem cells and chondrocytes and the potential for PRP to enhance cartilage regeneration as well as reduce catabolic factors that lead to cartilage degradation. This article provides an up-to-date review of the current literature regarding the effect of PRP on articular cartilage and its use in the treatment of osteoarthritis. Basic science, animal, and human clinical investigations are presented. In general, PRP has been shown to promote chondrogenic differentiation in vitro and lead to enhanced cartilage repair during animal investigations. Human trials, mostly conducted in the form of injection into knees with osteoarthritis, have shown promise in a number of investigations for achieving symptomatic relief of pain and improving function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24212369     DOI: 10.1097/JSA.0b013e3182999740

Source DB:  PubMed          Journal:  Sports Med Arthrosc Rev        ISSN: 1062-8592            Impact factor:   1.985


  28 in total

Review 1.  Research advances in cartilage stem cells markers and induced differentiation.

Authors:  Ting-Chen Mou; Jian-Ying Feng
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

Review 2.  Platelet-Rich Plasma and Cartilage Repair.

Authors:  Mitchell I Kennedy; Kaitlyn Whitney; Thos Evans; Robert F LaPrade
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

Review 3.  Learning about PRP using cell-based models.

Authors:  Knut Beitzel; Mary Beth McCarthy; Ryan P Russell; John Apostolakos; Mark P Cote; Augustus D Mazzocca
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

4.  Autologous platelet rich fibrin as a scaffold for chondrocyte culture and transplantation: An in vitro bovine study.

Authors:  Elizabeth Vinod; Deepak Vinod Francis; Tripti Jacob; Soosai Manickam Amirtham; Solomon Sathishkumar; Praghalathan Kanthakumar; Vinay Oommen
Journal:  J Clin Orthop Trauma       Date:  2019-04-26

Review 5.  Platelet rich plasma for treatment of osteochondral lesions of the talus: A systematic review of clinical trials.

Authors:  Oliver Emmanuel Yausep; Imad Madhi; Dionysios Trigkilidas
Journal:  J Orthop       Date:  2020-01-30

Review 6.  Current concepts and perspectives for articular cartilage regeneration.

Authors:  Livia Roseti; Brunella Grigolo
Journal:  J Exp Orthop       Date:  2022-07-01

7.  The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee.

Authors:  Alberto Gobbi; Dnyanesh Lad; Georgios Karnatzikos
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-20       Impact factor: 4.342

8.  Impact of Platelet-Rich Plasma Use on Pain in Orthopaedic Surgery: A Systematic Review and Meta-analysis.

Authors:  Herman Johal; Moin Khan; Shu-Hang Patrick Yung; Mandeep S Dhillon; Freddie H Fu; Asheesh Bedi; Mohit Bhandari
Journal:  Sports Health       Date:  2019-05-28       Impact factor: 3.843

9.  Effect of Combined Leukocyte-Poor Platelet-Rich Plasma and Hyaluronic Acid on Bone Marrow-Derived Mesenchymal Stem Cell and Chondrocyte Metabolism.

Authors:  Alexander M Satin; Jolanta B Norelli; Nicholas A Sgaglione; Daniel A Grande
Journal:  Cartilage       Date:  2019-07-07       Impact factor: 3.117

10.  In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis.

Authors:  Habib Zahir; Bijan Dehghani; Scott Rodeo; Miguel Otero; Xiaoning Yuan; Yurii Chinenov; Christine Kim; Alissa Burge; Reyna Bandhari; Daniel Nemirov; Patrick Fava; Peter Moley; Hollis Potter; Joseph Nguyen; Brian Halpern; Laura Donlin; Lionel Ivashkiv
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.